| Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives I Faravelli, M Bucchia, P Rinchetti, M Nizzardo, C Simone, E Frattini, ... Stem cell research & therapy 5, 1-13, 2014 | 76 | 2014 |
| Autophagy in motor neuron disease: key pathogenetic mechanisms and therapeutic targets MSC Mis, S Brajkovic, E Frattini, A Di Fonzo, S Corti Molecular and Cellular Neuroscience 72, 84-90, 2016 | 57 | 2016 |
| Mitochondrial dysregulation and impaired autophagy in iPSC-derived dopaminergic neurons of multiple system atrophy GM Compagnoni, G Kleiner, M Samarani, M Aureli, G Faustini, A Bellucci, ... Stem Cell Reports 11 (5), 1185-1198, 2018 | 55 | 2018 |
| Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches M Nizzardo, C Simone, S Dametti, S Salani, G Ulzi, S Pagliarani, F Rizzo, ... Scientific reports 5 (1), 11746, 2015 | 47 | 2015 |
| Pluripotent stem cell-based models of spinal muscular atrophy E Frattini, M Ruggieri, S Salani, I Faravelli, C Zanetta, M Nizzardo, ... Molecular and Cellular Neuroscience 64, 44-50, 2015 | 33 | 2015 |
| A practical approach to early-onset Parkinsonism GM Riboldi, E Frattini, E Monfrini, SJ Frucht, A Di Fonzo Journal of Parkinson's disease 12 (1), 1-26, 2022 | 29 | 2022 |
| Mutational analysis of COQ2 in patients with MSA in Italy D Ronchi, E Di Biase, G Franco, V Melzi, F Del Sorbo, A Elia, C Barzaghi, ... Neurobiology of Aging 45, 213. e1-213. e2, 2016 | 29 | 2016 |
| LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease M Kedariti, E Frattini, P Baden, S Cogo, L Civiero, E Ziviani, G Zilio, ... npj Parkinson's Disease 8 (1), 92, 2022 | 19 | 2022 |
| Mutations in TMEM230 are rare in autosomal dominant Parkinson's disease G Buongarzone, E Monfrini, G Franco, I Trezzi, L Borellini, E Frattini, ... Parkinsonism & related disorders 39, 87-88, 2017 | 13 | 2017 |
| Loss of the nucleoporin Aladin in central nervous system and fibroblasts of Allgrove syndrome G Bitetto, D Ronchi, S Bonato, A Pittaro, GM Compagnoni, A Bordoni, ... Human Molecular Genetics 28 (23), 3921-3927, 2019 | 12 | 2019 |
| β-Glucocerebrosidase deficiency activates an aberrant lysosome-plasma membrane axis responsible for the onset of neurodegeneration G Lunghi, EV Carsana, N Loberto, L Cioccarelli, S Prioni, L Mauri, R Bassi, ... Cells 11 (15), 2343, 2022 | 10 | 2022 |
| iPSC-based models to unravel key pathogenetic processes underlying motor neuron disease development I Faravelli, E Frattini, A Ramirez, G Stuppia, M Nizzardo, S Corti Journal of Clinical Medicine 3 (4), 1124-1145, 2014 | 9 | 2014 |
| Dysautonomia in Parkinson’s disease: impact of Glucocerebrosidase gene mutations on cardiovascular autonomic control A Carandina, G Lazzeri, GD Rodrigues, G Franco, E Monfrini, F Arienti, ... Frontiers in Neuroscience 16, 842498, 2022 | 8 | 2022 |
| Clinical Reasoning: A 75-year-old man with parkinsonism, mood depression, and weight loss E Frattini, E Monfrini, G Bitetto, B Ferrari, S Arcudi, N Bresolin, MC Saetti, ... Neurology 90 (12), 572-575, 2018 | 3 | 2018 |
| Neuronopathic Gaucher disease models reveal defects in cell growth promoted by Hippo pathway activation D Messelodi, S Strocchi, SN Bertuccio, P Baden, V Indio, FM Giorgi, ... Communications Biology 6 (1), 431, 2023 | 2 | 2023 |
| The activities of LRRK2 and GCase are positively correlated in clinical biospecimens and experimental models of Parkinson’s disease M Kedariti, E Frattini, P Baden, S Cogo, L Civiero, E Ziviani, M Aureli, ... BioRXiv, 2021.09. 27.461935, 2021 | 2 | 2021 |
| SARS-CoV-2 hampers dopamine production in iPSC-derived dopaminergic neurons G Cappelletti, EV Carsana, G Lunghi, S Breviario, C Vanetti, AB Di Fonzo, ... Experimental and Molecular Pathology 134, 104874, 2023 | 1 | 2023 |
| Neuropsychiatric symptoms in idiopathic brain calcification F ARIENTI, G FRANCO, G LAZZERI, E MONFRINI, I TREZZI, E FRATTINI, ... Minerva 64 (2), 240-9, 2023 | | 2023 |
| MODELLING GBA1-RELATED PARKINSON¿ S DISEASE PATHOLOGY IN PATIENT-DERIVED MIDBRAIN ORGANOIDS E Frattini Università degli Studi di Milano, 2023 | | 2023 |
| Plasma membrane and metabolic alterations as novel actors in the onset of GCase-related pathologies EV Carsana, G Lunghi, S Breviario, M Samarani, E Frattini, L Cioccarelli, ... FEBS OPEN BIO 12, 28-28, 2022 | | 2022 |
